Screener
Ionis Pharmaceuticals IONS Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 2:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000874015-26-000177
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Principal payments on mortgage debt | (44) | (42) |
| Net cash provided by financing activities | 57,258 | 2,199 |
| Effects of exchange rates on cash | (138) | 232 |
| Net increase (decrease) in cash and cash equivalents | (198,879) | 22,115 |
| Cash and cash equivalents at beginning of period | 372,260 | 242,077 |
| Cash and cash equivalents at end of period | $$173,381 | 264,192 |
| Supplemental disclosures of cash flow information: | ||
| Interest paid | $$90 | 92 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's net change in cash?
- Ionis Pharmaceuticals (IONS) reported net change in cash of -$198.88M in Q1 2026.
- How has Ionis Pharmaceuticals's net change in cash changed year-over-year?
- Ionis Pharmaceuticals's net change in cash decreased by 999.3% year-over-year, from $22.12M to -$198.88M.
- What is the long-term trend for Ionis Pharmaceuticals's net change in cash?
- Over 3 years (2021 to 2025), Ionis Pharmaceuticals's net change in cash has grown at a -34.9% compound annual growth rate (CAGR), from $471.53M to $130.18M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Ionis Pharmaceuticals's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude